67 related articles for article (PubMed ID: 3069731)
1. Suppression of transformed phenotypes and c-myc expression in a mouse plasmacytoma line after cell fusion with normal fibroblasts.
Oikawa T; Kondoh N; Ogiso Y; Kuzumaki N
IARC Sci Publ; 1988; (92):32-42. PubMed ID: 3069731
[No Abstract] [Full Text] [Related]
2. c-myc expression and transformed phenotypes in hybrid clones between mouse plasmacytoma S194 cells and normal spleen cells or fibroblasts.
Oikawa T; Yuhki Y; Kondoh N; Abe K; Yuhki N; Ogiso Y; Kuzumaki N
Int J Cancer; 1988 Sep; 42(3):435-40. PubMed ID: 3417371
[TBL] [Abstract][Full Text] [Related]
3. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
4. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
5. Suppression of transformed phenotypes in intraspecific somatic cell hybrid clones between the c-myc activating mouse plasmacytoma line and normal cells.
Oikawa T; Kuzumaki N; Yamada T; Chiba I; Yamagiwa S
Int J Cancer; 1987 May; 39(5):604-10. PubMed ID: 3570552
[TBL] [Abstract][Full Text] [Related]
6. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
7. Expression of the vav oncogene in somatic cell hybrids.
Denkinger DJ; Kawahara RS
Exp Cell Res; 1997 May; 232(2):388-94. PubMed ID: 9168816
[TBL] [Abstract][Full Text] [Related]
8. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
Roman S; Moore JS; Darby C; Müller S; Hoover RG
J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
[TBL] [Abstract][Full Text] [Related]
11. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
[TBL] [Abstract][Full Text] [Related]
12. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
Zerlin M; Julius MA; Cerni C; Marcu KB
Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells.
Fernandez A; Marin MC; McDonnell T; Ananthaswamy HN
Oncogene; 1994 Jul; 9(7):2009-17. PubMed ID: 8208546
[TBL] [Abstract][Full Text] [Related]
15. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
16. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype.
Kowara R; Karaczyn A; Cheng RY; Salnikow K; Kasprzak KS
Toxicol Appl Pharmacol; 2005 May; 205(1):1-10. PubMed ID: 15885260
[TBL] [Abstract][Full Text] [Related]
20. Type C virus particles in X63-Ag8.653 mouse plasmacytoma cells and in hybridomas derived from it.
Rudolph M; Karsten U; Micheel B
Arch Geschwulstforsch; 1983; 53(6):513-9. PubMed ID: 6670912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]